By Jess Krochtengel ( October 5, 2015, 7:47 PM EDT) -- A Texas appellate court on Friday stood by its reinstatement of a $1.875 million arbitration award in a dispute over patent licensing for technology used to treat excessive human growth hormone, despite a biotech firm's argument that the arbitrators exceeded a contractual limit on damages....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.